Suppr超能文献

相似文献

1
Liver cancer stem cells.
J Clin Oncol. 2008 Jun 10;26(17):2800-5. doi: 10.1200/JCO.2007.15.5945.
2
Histopathology of liver cancers.
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):39-62. doi: 10.1016/j.bpg.2004.10.007.
3
Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):15-26. doi: 10.1289/ehp.93101s515.
4
Stemness and reprogramming in liver cancer.
Hepatology. 2016 Apr;63(4):1068-70. doi: 10.1002/hep.28362. Epub 2016 Jan 14.
7
Proliferative drive and liver carcinogenesis: too much of a good thing?
J Gastroenterol Hepatol. 2009 Dec;24(12):1817-25. doi: 10.1111/j.1440-1746.2009.06121.x.
8
Evidence regarding a stem cell origin of hepatocellular carcinoma.
Stem Cell Rev. 2005;1(3):261-4. doi: 10.1385/SCR:1:3:261.
10
Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Am J Physiol Gastrointest Liver Physiol. 2016 Jul 1;311(1):G91-G104. doi: 10.1152/ajpgi.00027.2015. Epub 2016 May 5.

引用本文的文献

1
Current status and new directions for hepatocellular carcinoma diagnosis.
Liver Res. 2024 Dec 5;8(4):218-236. doi: 10.1016/j.livres.2024.12.001. eCollection 2024 Dec.
2
Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects.
Front Immunol. 2024 Aug 23;15:1446532. doi: 10.3389/fimmu.2024.1446532. eCollection 2024.
3
Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression.
Oncol Rev. 2024 Jul 18;18:1411736. doi: 10.3389/or.2024.1411736. eCollection 2024.
4
Liposome-lentivirus for miRNA therapy with molecular mechanism study.
J Nanobiotechnology. 2024 Jun 10;22(1):329. doi: 10.1186/s12951-024-02534-0.
5
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma.
Discov Oncol. 2024 May 7;15(1):144. doi: 10.1007/s12672-024-01002-3.
7
Clinical significance of RNA methylation in hepatocellular carcinoma.
Cell Commun Signal. 2024 Apr 2;22(1):204. doi: 10.1186/s12964-024-01595-w.
8
UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4.
BMC Cancer. 2024 Jan 17;24(1):93. doi: 10.1186/s12885-023-11794-2.

本文引用的文献

1
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Cancer Res. 2008 Mar 1;68(5):1451-61. doi: 10.1158/0008-5472.CAN-07-6013.
2
Identification of local and circulating cancer stem cells in human liver cancer.
Hepatology. 2008 Mar;47(3):919-28. doi: 10.1002/hep.22082.
3
Significance of CD90+ cancer stem cells in human liver cancer.
Cancer Cell. 2008 Feb;13(2):153-66. doi: 10.1016/j.ccr.2008.01.013.
4
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
5
Wnt/beta-catenin signaling mediates oval cell response in rodents.
Hepatology. 2008 Jan;47(1):288-95. doi: 10.1002/hep.21973.
6
Cancer stem cells in radiation resistance.
Cancer Res. 2007 Oct 1;67(19):8980-4. doi: 10.1158/0008-5472.CAN-07-0895.
7
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.
Oncogene. 2008 Mar 13;27(12):1749-58. doi: 10.1038/sj.onc.1210811. Epub 2007 Sep 24.
8
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.
Gastroenterology. 2007 Sep;133(3):937-50. doi: 10.1053/j.gastro.2007.06.016. Epub 2007 Jun 20.
9
A CD133-expressing murine liver oval cell population with bilineage potential.
Stem Cells. 2007 Oct;25(10):2419-29. doi: 10.1634/stemcells.2007-0176. Epub 2007 Jun 21.
10
Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
Gastroenterology. 2007 Jun;132(7):2542-56. doi: 10.1053/j.gastro.2007.04.025. Epub 2007 Apr 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验